GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2018 8
Important citations (462)

ahmed tm, ahmed aa. immunohistochemical expression of cd26 in bone marrow biopsies of chronic lymphocytic leukemia patients. indian journal of public health research & development. 2019 feb 1;10(2).

vosoughi t, bagheri m, hosseinzadeh m, ehsanpour a, davari n, saki n. cd markers variations in chronic lymphocytic leukemia: new insights into prognosis. journal of cellular physiology. 2019 may 2.

abdelrahman ah, ibrahim mh, hamza mt, eid om, hassan em, kamel sa, eid mm, shahin ry, sallam mt. relevance of cd49d and cd38 expressions as predictors of disease progression in chronic lymphocytic leukemia. the egyptian journal of haematology. 2018 apr 1;43(2):88.

Zaki em, el-gammal sa, sayed ng, sediek mf, mohamed aa. the prognostic implication of cd49d expression by flow cytometry and trisomy 12 detection by fluorescent in situ hybridization in chronic lymphocytic leukemia. journal of advances in medicine and medical research. 2019 mar 20:1-9.

enz n, vliegen g, de meester i, jungraithmayr w. cd26/dpp4-a potential biomarker and target for cancer therapy. pharmacology & therapeutics. 2019 jun 1;198:135-59.

vaisitti t, arruga f, deaglio s. targeting the adenosinergic axis in chronic lymphocytic leukemia: a way to disrupt the tumor niche?. international journal of molecular sciences. 2018 apr;19(4):1167.

hendy om, el shafie ma, allam mm, motalib ta, khalaf fa, gohar sf. the diagnostic and prognostic value of cd38 and cd49d expressions in chronic lymphocytic leukemia. the egyptian journal of haematology. 2016 apr 1;41(2):70.

ye c, tian x, yue g, yan l, guan x, wang s, hao c. suppression of cd26 inhibits growth and metastasis of pancreatic cancer. tumor biology. 2016 dec 1;37(12):15677-86.

Hasan f, parashar y, rao rn, kashyap r. leonine facies: a unique presentation of t-prolymphocytic leukemia. indian j pathol microbiol 2021;64:817-9

Mota c. detection of intracellular cytokeratin 20 in cd14dim monocytes: a potential tool for the screening of colorectal adenocarcinoma in peripheral blood (doctoral dissertation).

özcan a. akut myeloid lösemi hastalarında kopya sayısı deÄŸiÅŸikliklerinin dizin temelli karşılaÅŸtırmalı genomik hibridizasyon yöntemi ile deÄŸerlendirilmesi.

Shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

Shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

Kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112.

Shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

Roop p, angmo d, kamble n, tomar as. uncontrolled neovascular glaucoma–an alarming manifestation of chronic myeloid leukemia on imatinib therapy–a case report and review of literature. indian journal of ophthalmology. 2019 feb;67(2):285.

Kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112.

arigi j. mini review on dengue fever. research & reviews: journal of hospital and clinical pharmacy (2016).

nayak d. letter to editor (viewers choice). brain. 2000;123:205-21.

kamini j. bone marrow transplantation: a review. research & reviews: research journal of biology (2016).

Top